BRCA gene mutations can significantly raise a woman’s risk of breast and ovarian cancer. Know how hereditary cancer risk works and why genetic testing and early screening matter.

A clustered family history of breast, ovarian, and colon cancers appropriately triggered germline testing, with BRCA1 mutation status informing individualized risk stratification and counseling.

Breast cancer is a prevalent cancer in women across the globe. Although a majority of the instances are isolated, hereditary cases associated with genetic mutations are found in 5-10 percent. Of these ...

We talked to experts about new research connecting mutations in BRCA genes to other forms of cancer besides breast and ovarian. If you typically think of BRCA gene mutations along with certain breast ...

Risk assessments for cancers related to BRCA mutations could save lives. Annually, about 247,200 cases of breast cancer are diagnosed in the U.S. and nearly 42,000 people die each year from breast ...

(WASHINGTON, June 13, 2025) – Women with breast cancer who were also carriers of the BRCA1 or BRCA2 mutation and received textured breast implants as part of their reconstructive surgery after ...

In young BRCA carriers who survived breast cancer, assisted reproductive techniques (ART) did not increase the risk of disease recurrence or adversely affect pregnancy outcomes, findings of an ...

Lynparza significantly improves iDFS, DDFS, and OS in BRCA1/2 mutation-positive, HER2-negative high-risk breast cancer patients. The trial's six-year analysis shows consistent benefits across all ...

Of the more than 3 million people with breast cancer in the United Stated, about 10 percent carry an inherited mutation in their BRCA1 gene. In health, the gene is responsible for suppressing tumors.

Patients with BRCA-mutant breast cancer had a significantly higher risk of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), a large cohort study showed. BRCA1/2 mutations conferred ...

Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A ...

“Breast cancer was the furthest thing from my mind,” Jacob Johnson tells PEOPLE ...